Diabetes
181 - 195 of
437 Results
Sort Results:
Article:
More payers are trying to rein in the use of antipsychotics in patients WITHOUT psychotic disorders
December 2013
Article:
More payers will recognize the value of pharmacists in improving the quality of patient care
November 2013
Article:
Experts will debate whether gliptins (Onglyza, etc) increase cardiovascular risk in patients with type 2 diabetes
November 2013
Article:
More patients will get aspirin plus a SHORT course of clopidogrel immediately after a minor ischemic stroke or TIA
September 2013
Article:
Nesina (nes-SEE-na, alogliptin) will compete in a crowded market of gliptins, or DPP-4 inhibitors, for type 2 diabetes
August 2013
Article:
Belviq (bel-VEEK, lorcaserin) will join Qsymia and other weight loss meds in the battle of the bulge
July 2013
Article:
more emphasis on preventing and treating hypoglycemia in patients with type 2 diabetes
June 2013
Article:
Invokana (in-vo-KAHN-uh, canagliflozin), the first in a new class of oral drugs for type 2 diabetes
May 2013
Article:
Signifor (SIG-na-for, pasireotide) is a new option for treating Cushing's disease
April 2013